MIBRAR® for Hip Joint — Regeneration Without Replacement

The hip joint is the largest and most loaded joint in the human body. Coxarthrosis, avascular necrosis, impingement syndrome — these diseases lead to pain, limping, and disability. MIBRAR® allows joint restoration without replacement with an artificial one.

Hip Joint Conditions Treated with MIBRAR®

• Coxarthrosis — hip joint cartilage degeneration (stages 1–3)
• Avascular necrosis of the femoral head
• Impingement syndrome — bony structure impingement
• Labral tear — acetabular labrum damage
• Bursitis — trochanteric bursa inflammation
• Tendinopathy — gluteus medius tendon damage
• Dysplasia — with secondary arthrosis

How MIBRAR® Restores the Joint

The ARK® concentrate is injected into the hip joint under ultrasound guidance:

• Stem cells regenerate cartilage tissue of joint surfaces
• Growth factors restore blood supply to the femoral head
• Anti-inflammatory cytokines reduce synovitis and swelling
• Synovial fluid quality improves

The procedure is performed on an outpatient basis, without anesthesia. The patient can load the leg the very next day.

Indications

MIBRAR® for hip joint is recommended when:

• Conservative treatment is ineffective
• Hyaluronic acid and PRP injections provide only temporary relief
• Joint replacement is being suggested but the patient wants to preserve the joint
• There are contraindications to general anesthesia
• Rapid recovery is required

Results and Cost

• Pain reduction — from the first days
• Gait improvement — 2–4 weeks
• Cartilage regeneration on MRI — 3–6 months
• Overall improvement up to 85% — by 8–16 weeks